Effects of the combined action of a desensitizing gel and toothpaste on dentin hypersensitivity due to dental bleaching

Objectives: The present study is aimed at evaluating the effectiveness of a fluoride- and potassium nitrate-containing gel and toothpaste in reducing dentinal hypersensitivity due to dental bleaching. Materials and methods: Specific inclusion and exclusion criteria were used to recruit patients for the study. They were randomly allocated to a test or a placebo control group. Patients underwent a treatment of home dental bleaching with 10% carbamide peroxide. Dental shades were evaluated in a standardized environment and dentinal hypersensitivity was valuated by means of evaporation stimuli. A nominal scale was used to score the painful reaction. The patients were recalled 8, 15 and 28 days after the baseline for both shade and sensitivity assessment. Statistical analysis was performed using the Student’s T-test. Results: The patients recall rate was 96.9%. The statistical analysis demonstrated a significant reduction of the painful symptoms in the experimental group (p=0.031) while no statistically significant differences were evidenced in the control group at any follow-up recall (p>0.05). Discussion: The tested agents proved to be safe and effective in the short term. Neither pigmentations nor interferences with the bleaching action of peroxides due to the desensitizing agents were observed. The compliance of the patients to the proposed protocol as well as the motivation to maintain good oral hygiene were paramount in the achievement of the reported results. Conclusions: The use of a desensitizing gel and toothpaste containing fluoride and potassium nitrate was effective in reducing dentinal hypersensitivity due to dental bleaching and did not interfere with the bleaching action of peroxides. Clinical significance: Desensitizing gels and toothpastes containing fluoride and potassium nitrate can be considered safe and effective in the control of tooth sensitivity after dental bleaching

Antibodies to combat viral infections: development strategies and progress.

Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophylactics for viral infections owing to characteristics such as their high specificity and their ability to enhance immune responses. Furthermore, antibody engineering can be used to strengthen effector function and prolong mAb half-life, and advances in structural biology have enabled the selection and optimization of potent neutralizing mAbs through identification of vulnerable regions in viral proteins, which can also be relevant for vaccine design. The COVID-19 pandemic has stimulated extensive efforts to develop neutralizing mAbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with several mAbs now having received authorization for emergency use, providing not just an important component of strategies to combat COVID-19 but also a boost to efforts to harness mAbs in therapeutic and preventive settings for other infectious diseases. Here, we describe advances in antibody discovery and engineering that have led to the development of mAbs for use against infections caused by viruses including SARS-CoV-2, respiratory syncytial virus (RSV), Ebola virus (EBOV), human cytomegalovirus (HCMV) and influenza. We also discuss the rationale for moving from empirical to structure-guided strategies in vaccine development, based on identifying optimal candidate antigens and vulnerable regions within them that can be targeted by antibodies to result in a strong protective immune response

Comparative Raman Study of Organic-Free and Surfactant-Capped Rod-Shaped Anatase TiO2 Nanocrystals

Excitation of lattice vibrations in nanostructured anatase TiO2 frequently occurs at energy values differing from that found for the corresponding bulk phase. Particularly, investigations have long aimed at establishing a correlation between the low-frequency E-g(1) mode and the mean crystallite size on the basis of phonon-confinement models. Here, we report a detailed Raman study, supported by X-ray diffraction analyses, on anatase TiO2 nanocrystals with rod-shaped morphology and variable geometric parameters, prepared by colloidal wet-chemical routes. By examining the anomalous shifts of the E-g(1) mode in the spectra of surfactant-capped nanorods and in those of corresponding organic-free derivatives (obtained by a suitable thermal oxidative treatment), an insight into the impact of exposed facets and of the coherent crystalline domain size on Raman-active lattice vibrational modes has been gained. Our investigation offers a ground for clarifying the current lack of consensus as to the applicability of phonon-confinement models for drawing information on the size of surface-functionalized TiO2 nanocrystals upon analysis of their Raman features

Parametric multi-objective optimization of an Organic Rankine Cycle with thermal energy storage for distributed generation

Abstract This paper focuses on the thermodynamic modelling and parametric optimization of an Organic Rankine Cycle (ORC) which recovers the heat stored in a thermal energy storage (TES). A TES with two molten-salt tanks (one cold and one hot) is selected since it is able to operate in the temperature range useful to recover heat from different sources such as exhaust gas of Externally Fired Gas Turbine (EFGT) or Concentrating Solar Power (CSP) plant, operating in a network for Distributed Generation (DG). The thermal storage facilitates a flexible operation of the power system operating in the network of DG, and in particular allows to compensate the energy fluctuations of heat and power demand, increase the capacity factor of the connected plants, increase the dispatchability of the renewable energy generated and potentially operate in load following mode. The selected ORC is a regenerative cycle with the adoption of a Heat Recovery Vapour Generator (HRVG) that recovers heat from molten salts flowing from the Hot Tank to the Cold Tank of the TES. By considering the properties of molten salt mixtures, a ternary mixture able to operate between 200 and 400 °C is selected. The main ORC parameters, namely the evaporating pressure/temperature and the evaporator/condenser pinch point temperature differences, are selected as variables for the thermodynamic ORC optimization. An automatic optimization procedure is set up by means of a genetic algorithm (GA) coupled with an in-house code for the ORC calculation. Firstly, a mono-objective optimization is carried out for two working fluids of interest (Toluene and R113) by maximization of the cycle thermal efficiency. Afterwards, a multi-objective optimization is carried out for the fluid with the best performance by means of a Non-dominated Sorting Genetic Algorithm (NSGA) in order to evaluate the cycle parameters which maximize the thermal efficiency and minimise the heat exchanger surface areas. Toluene results able to give the best trade-off between efficiency and heat exchanger dimensions for the present application, showing that by with respect to the best efficiency point, the heat exchange area can be reduced by 36% with only a penalty of 1% for the efficiency

GABAergic and glycinergic inputs modulate rhythmogenic mechanisms in the lamprey respiratory network

We have previously shown that GABA and glycine modulate respiratory activity in the in vitro brainstem preparations of the lamprey and that blockade of GABA(A) and glycine receptors restores the respiratory rhythm during apnoea caused by blockade of ionotropic glutamate receptors. However, the neural substrates involved in these effects are unknown. To address this issue, the role of GABA(A), GABA(B) and glycine receptors within the paratrigeminal respiratory group (pTRG), the proposed respiratory central pattern generator, and the vagal motoneuron region was investigated both during apnoea induced by blockade of glutamatergic transmission and under basal conditions through microinjections of specific antagonists. The removal of GABAergic, but not glycinergic transmission within the pTRG, causes the resumption of rhythmic respiratory activity during apnoea, and reveals the presence of a modulatory control of the pTRG under basal conditions. A blockade of GABA(A) and glycine receptors within the vagal region strongly increases the respiratory frequency through disinhibition of neurons projecting to the pTRG from the vagal region. These neurons were retrogradely labelled (neurobiotin) from the pTRG. Intense GABA immunoreactivity is observed both within the pTRG and the vagal area, which corroborates present findings. The results confirm the pTRG as a primary site of respiratory rhythm generation, and suggest that inhibition modulates the activity of rhythm-generating neurons, without any direct role in burst formation and termination mechanisms

P17-23. Enhanced expression of HIV antigens and improved antigen presentation after infection with replication competent attenuated vaccinia virus in vitro

1 página.-- Presentación de póster presentation.-- Este artículo es parte del suplemento: AIDS Vaccine 2009.Peer reviewe

Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial.

In a placebo-controlled trial of the peptide-based therapeutic HIV-1 p24 <sup>Gag</sup> vaccine candidate Vacc-4x, participants on combination antiretroviral therapy (cART) received six immunizations over 18weeks, followed by analytical treatment interruption (ATI) between weeks 28 and 52. Cell-mediated immune responses were investigated as predictors of Vacc-4x effect (VE) on viral load (VL) and CD4 count during ATI. All analyses of week 28 responses and fold-changes relative to baseline considered per-protocol participants (Vacc-4x:placebo=72:32) resuming cART after week 40. Linear regression models with interaction tests were used. VE was estimated as the Vacc-4x-placebo difference in log <sub>10</sub> -transformed VL (VE <sup>VL</sup> ) or CD4 count (VE <sup>CD4</sup> ). A lower fold-change of CD4+ T-cell proliferation was associated with VE <sup>CD4</sup> at week 48 (p=0.036, multiplicity adjusted q=0.036) and week 52 (p=0.040, q=0.080). A higher fold-change of IFN-γ in proliferation supernatants was associated with VE <sup>VL</sup> at week 44 (p=0.047, q=0.07). A higher fold-change of TNF-α was associated with VE <sup>VL</sup> at week 44 (p=0.045, q=0.070), week 48 (p=0.028, q=0.070), and week 52 (p=0.037, q=0.074). A higher fold-change of IL-6 was associated with VE <sup>VL</sup> at week 48 (p=0.017, q=0.036). TNF-α levels (>median) were associated with VE <sup>CD4</sup> at week 48 (p=0.009, q=0.009). These exploratory analyses highlight the potential value of investigating biomarkers in T-cell proliferation supernatants for VE in clinical studies